Morning Overview on MSN

The first cellular age-reversal therapy has been cleared for human trials

Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy designed to reverse cellular aging in the human eye. The trial, registered as ...
Morning Overview on MSN

A Harvard scientist says his team is preparing the first human trials aimed at reversing aging

A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in the human eye. The study, called ER-100, uses a gene therapy vector to ...